By 2018, over 40 countries and more than 75% of global medicine supply will be covered by one or more track and trace regulations. Companies serving global patients face complex serialization, traceability, verification and government reporting regulations.
Meeting regulations from the U.S. and EU to China and Brazil requires not just preparing your company but also connecting to and coordinating with your diverse supply network of CMOs/CPOs, pharma companies, wholesalers, pharmacies and government agencies.Learn More
Companies face massive challenges in dealing with the growing diversity and complexity in pharmaceutical serialization requirements. Unique product identifiers vary across countries, serial number formats diverge from global GS1 standards into country-specific versions (China, Brazil, etc.) and aggregation creates complex data management issues.
Ensuring serialized products get to market demands a comprehensive global strategy and supporting network IT architecture. Starting early is crucial.Learn More
Outsourced manufacturing and packaging is a strategic part of today's Life Sciences supply network operations. With over 40% of today's pharmaceutical production estimated to be done by CMOs and CPOs, high performance collaboration with supply partners is crucial.
This requires rethinking how pharmaceutical companies work with their external manufacturing partners. The goal should be to have the same level of visibility, coordination and control across the external manufacturing process that companies have throughout their own production assets and sites.Learn More
The complexity of a company's supply network has exploded in recent years as businesses not only leverage external manufacturing partners but also search the world for the best suppliers of materials ranging from active ingredients and excipients to packaging bottles and paper clips.
Ensuring the quality and reliability of these suppliers and the products they provide is paramount in the highly regulated Life Sciences industry as you produce and distribute life saving medicines to global patients. You need visibility and control over these sources.Learn More
Keeping patients safe from counterfeit drugs while supporting their health with medicines and information is crucial. Reaching the patient whether they are in the United States or Uganda is a particular challenge given complicated global supply chains and traditionally limited ways of communicating knowledge.
The explosion of mobile devices ranging from smart phones to tablets present a unique opportunity to transform the relationship with the patient, enabling companies to establish a true bi-directional conversation with patients and care givers.Learn More